Literature DB >> 33749252

Structural Alterations of Mucins Are Associated with Losses in Functionality.

Matthias Marczynski1,2, Kun Jiang3,4,5, Matthew Blakeley3, Vaibhav Srivastava3, Francisco Vilaplana3, Thomas Crouzier3,4,5, Oliver Lieleg1,2.   

Abstract

Commercial mucin glycoproteins are routinely used as a model to investigate the broad range of important functions mucins fulfill in our bodies, including lubrication, protection against hostile germs, and the accommodation of a healthy microbiome. Moreover, purified mucins are increasingly selected as building blocks for multifunctional materials, i.e., as components of hydrogels or coatings. By performing a detailed side-by-side comparison of commercially available and lab-purified variants of porcine gastric mucins, we decipher key molecular motifs that are crucial for mucin functionality. As two main structural features, we identify the hydrophobic termini and the hydrophilic glycosylation pattern of the mucin glycoprotein; moreover, we describe how alterations in those structural motifs affect the different properties of mucins-on both microscopic and macroscopic levels. This study provides a detailed understanding of how distinct functionalities of gastric mucins are established, and it highlights the need for high-quality mucins-for both basic research and the development of mucin-based medical products.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33749252     DOI: 10.1021/acs.biomac.1c00073

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  5 in total

1.  Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease.

Authors:  Aran Singanayagam; Joseph Footitt; Matthias Marczynski; Giorgia Radicioni; Michael T Cross; Lydia J Finney; Maria-Belen Trujillo-Torralbo; Maria Calderazzo; Jie Zhu; Julia Aniscenko; Thomas B Clarke; Philip L Molyneaux; Nathan W Bartlett; Miriam F Moffatt; William O Cookson; Jadwiga Wedzicha; Christopher M Evans; Richard C Boucher; Mehmet Kesimer; Oliver Lieleg; Patrick Mallia; Sebastian L Johnston
Journal:  J Clin Invest       Date:  2022-04-15       Impact factor: 19.456

Review 2.  Advances in MUC1-Mediated Breast Cancer Immunotherapy.

Authors:  Zhifeng Li; Dazhuang Yang; Ting Guo; Mei Lin
Journal:  Biomolecules       Date:  2022-07-06

3.  Identification of mucin degraders of the human gut microbiota.

Authors:  Stefano Raimondi; Eliana Musmeci; Francesco Candeliere; Alberto Amaretti; Maddalena Rossi
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

Review 4.  MUC1: Structure, Function, and Clinic Application in Epithelial Cancers.

Authors:  Wenqing Chen; Zhu Zhang; Shiqing Zhang; Peili Zhu; Joshua Ka-Shun Ko; Ken Kin-Lam Yung
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

5.  Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?

Authors:  Gemma Conte; Gabriella Costabile; Domizia Baldassi; Valeria Rondelli; Rosaria Bassi; Diego Colombo; Giulia Linardos; Ersilia V Fiscarelli; Raffaella Sorrentino; Agnese Miro; Fabiana Quaglia; Paola Brocca; Ivana d'Angelo; Olivia M Merkel; Francesca Ungaro
Journal:  ACS Appl Mater Interfaces       Date:  2022-02-02       Impact factor: 9.229

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.